Increased risk, but research doesn't establish cause-and-effect relationship
Study reveals a 35% increase in all-cause mortality risk compared with non-use.
Researchers suggest 300 minutes weekly of activities such as walking or gardening.
Key features include elimination of treatment targets, additional testing only when rationale clear
Low yield among patients presenting with acute chest pain and low clinical risk
Risk is low; however, heart patients are advised to keep phones away from chest pockets.
Only 25% of men and 33% of women in the U.S. are at a healthy weight, researchers say.
Hemodialysis patients treated with either agent have comparable risks of overall and cardiovascular mortality and cardiovascular events.
After standard lipid treatments, CKD patients still have up to a 70% residual risk of cardiovascular disease.
International effort takes aim at more than 1,050 websites
Surgical patients who suffer complications after hospital discharge are more likely to die if they're readmitted to a different hospital than where they had their original operation.
Men who slept badly were twice as likely to suffer a heart attack and up to four times as likely to have a stroke.
U.S. FDA gives food manufacturers 3 years to remove partially hydrogenated oils from the food supply.
Findings in older men with high cholesterol and low testosterone.
Benefits were observed in Caucasian men and women consuming as much as 3.5 ounces of chocolate a day.
Stronger correlation for MI risk with updated latest and updated mean versus baseline HbA1c.
No increased risk seen with H2-blockers, by comparison.
Lowering of LDL cholesterol levels, improved cardiovascular outcomes for simvastatin ezetimibe.
Highest versus lowest intake associated with a 67% and 88% lower risk of all-cause and cardiovascular mortality, respectively.
Fewer invasive coronary angiography procedures, higher CAD yield for patients with suspected CAD.
FDA panel recommends approval of evolocumab (Repatha) for use in patients at very high risk for high cholesterol.
Increase in free fatty acids, triglycerides; decrease in low- and high-density lipoprotein cholesterol.
Greater decline in glomerular filtration rate for warfarin versus dabigatran etexilate among atrial fibrillation patients.
A PCSK9 Inhibitor could be used by patients who don't respond to statins.
Findings among patients with type 2 diabetes and established cardiovascular disease.
Lower odds for consulting complementary and alternative medicine practitioner, taking CAM
Study findings show that contrast dosing is only a minor contributor to the overall burden of AKI.
Patients taking a statin had lower mortality risk in weeks after the surgery, researchers say.
But study showed it's not enough to prevent related deaths.
Findings in patients with pulmonary hypertension linked to heart failure and preserved ejection fraction
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)